REQUEST A DEMO
Total
USD $0.00
Search more companies

Zentiva SA (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Zentiva SA Profile Updated: February 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Zentiva representative in Romania was founded in 2000. Zentiva’s shares are traded on the Bucharest Stock Exchange from 13.08.1998 under the symbol SCD. Zentiva SA is an international pharmaceutical company that is focused on developing, manufacturing and marketing of modern branded generic pharmaceutical products. Zentiva Group has production sites in the Czech Republic, Slovakia, Romania and Turkey. Zentiva shares are traded on the Prague Stock Exchange and its shares are traded on global stock warehouse in London.

Headquarters
Strada Theodor Pallady Nr. 50
Bucharest; Bucharest;

Contact Details: Purchase the Zentiva SA report to view the information.

Basic Information
Total Employees:
Purchase the Zentiva SA report to view the information.
Outstanding Shares:
Purchase the Zentiva SA report to view the information.
Registered Capital:
Purchase the Zentiva SA report to view the information.
Financial Auditors:
Purchase the Zentiva SA report to view the information.
Incorporation Date:
February 09, 1991
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
95.9486%
Purchase this report to view the information.
4.0127%
Purchase this report to view the information.
0.0387%
Company Performance
Financial values in the chart are available after Zentiva SA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
27.23%
Total operating revenue
23.87%
EBITDA
N/A
Net Profit (Loss) for the Period
268.52%
Total assets
20.15%
Total equity
21.51%
Net Profit Margin
11.85%
Return on Equity (ROE)
7.39%
Debt to Equity Ratio
0.78%
Quick Ratio
0.28%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?